Weekly Variability of Plasma and Serum NT-pro-BNP Measurements in Normal Dogs
ACVIM 2008
H.B. Kellihan1; M.A. Oyama2; C.A. Reynolds2; R.L. Stepien1
1University of Wisconsin School of Veterinary Medicine, Madison, WI, USA; 2University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA

N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentration has been used to identify cardiovascular causes of dyspnea in dogs. However, the day-to-day variability of circulating NT-proBNP in dogs is not known. The purpose of this study was to examine the weekly variability of NT-proBNP concentration in normal dogs.

Thirty-seven clinically normal dogs from 2 study sites were examined prospectively. All dogs had normal cardiac auscultation and no significant abnormalities on 2-D, M-mode and Doppler echocardiographic examinations. Serum samples from site A (n=19) and plasma samples from site B (n=18) for NT-proBNP assay (Canine CardioCare, Veterinary Diagnostics Institute, Irvine, CA) were obtained from dogs at one week intervals for a total of 3 samples.

The median age of the patient population was 5 years (range: 0.8-10 years), whereas the median weight was 22 kilograms (range: 5-50 kilograms). There was no significant difference in median NT-proBNP for all dogs between week 1 (378 pmol/L [25-75% interquartile range: 219-485 pmol/L], week 2 (366 pmol/L [231-496]), and week 3 (367 pmol/L [223-469]) (p=0.99). However, the coefficients of variation (CV=standard deviation/average) for individual dogs ranged from 0-51% (median CV=12%). Eighteen of 37 dogs (49%) had CV <12%, 15 of 37 dogs (41%) had CV of 12-30%, and 4 of 37 dogs (11%) had CV >30%. Six of 37 dogs (16%) possessed one NT-proBNP reading that exceeded the manufacturer's current upper normal value of 566 pmol/L. Two of 37 dogs (5%) possessed two readings >566 pmol/L, and in 2 of 37 dogs (5%) all three weekly results were >566 pmol/L. The median serum NT-proBNP concentration of dogs from study site A was significantly higher than plasma concentrations of dogs from study site B, (Site A, 420 pmol/L [25-75% interquartile range: 296-542 pmol/L], vs. Site B, 257 pmol/L, [162-432]; p=<0.001), suggesting either a difference between serum and plasma concentrations vs. a regional difference in the study population.

Weekly variability of NT-proBNP measurement is generally low, however, in a small percentage of dogs, variability has the potential to confound a single result and serial measurements are recommended.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Heidi Kellihan, DVM, DACVIM (Cardiology)
Madison, WI

MAIN : SA Cardiology : NT-proBNP Measurements
Powered By VIN